Leadership is a quality that is difficult to define, let alone acquire. Any definition is usually influenced by the biases of the person doing the defining. We might say that defining leadership is a bit like defining art. As the saying goes, "I don't know what art is, but I know it when I see it." That sort of statement may end the discussion about defining art or leadership, but it is not helpful in the least for those of us who need leaders, or want to be leaders, in a world that seems desperately short of people we want to follow. In this book, Coach "D" takes a fresh look at leadership. He blows the whistle on some misconceptions about leadership, and gets to the heart of the matter - which is the heart! As a devout Christian, Coach "D" realizes that leadership is a character trait that is basic to who we are. And it is the outpouring of a heart committed to God. Leadership can be broken down into its various aspects, which Coach "D" has done for the reader, but at its essence it is a quality of Jesus Christ, a quality which we are able to imitate as our hearts are turned more and more toward the heart of God. Jesus both taught and demonstrated the idea of servant leadership, in which a leader must be willing to serve those he leads. This requires great humility, something we don't always associate with leadership. And it requires integrity, that character trait that transcends all others. In this book, Coach "D" has taken the leadership qualities taught and modeled by Jesus and applied them to the world of today, especially the world of our young people.

A critical examination of translational medicine, when private risk is transferred to the public sector and university research teams become tech startups for global investors. A global shift has secretly transformed science and medicine. Starting in 2003, biomedical research in the West has been reshaped by the emergence of translational science and medicine-the idea that the aim of research is to translate findings as quickly as possible into medical products. In The Market in Mind, Mark Dennis Robinson charts this shift, arguing that the new research paradigm has turned university research teams into small biotechnology startups and their industry partners into early-stage investment firms. There is also a larger, surprising consequence from this shift: according to Robinson, translational science and medicine enable biopharmaceutical firms, as part of a broader financial strategy, to outsource the riskiest parts of research to nonprofit universities. Robinson examines the implications of this new configuration. What happens, for example, when universities absorb unknown levels of risk? Robinson argues that in the years since the global financial crisis translational science and medicine has brought about "the financialization of health." Robinson explores such topics as shareholder anxiety and industry retreat from Alzheimer's and depression research; how laboratory research is understood as health innovation even when there is no product; the emergence of investor networking events as crucial for viewing science in a market context; and the place of patients in research decisions. Although translational medicine justifies itself by the goal of relieving patients' suffering, Robinson finds patients' voices largely marginalized in translational neuroscience.